<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity - Demetrios, M - 2013 | Cochrane Library</title> <meta content="Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity - Demetrios, M - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009689.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity - Demetrios, M - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009689.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009689.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity" name="citation_title"/> <meta content="Marina Demetrios" name="citation_author"/> <meta content="Royal Melbourne Hospital, Royal Park Campus" name="citation_author_institution"/> <meta content="marina.demetrios@mh.org.au" name="citation_author_email"/> <meta content="Fary Khan" name="citation_author"/> <meta content="Royal Melbourne Hospital, Royal Park Campus" name="citation_author_institution"/> <meta content="Lynne Turner‐Stokes" name="citation_author"/> <meta content="King's College London and Northwick Park Hospital" name="citation_author_institution"/> <meta content="Caroline Brand" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="Shane McSweeney" name="citation_author"/> <meta content="Guide Dogs Victoria" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD009689.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/06/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009689.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009689.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009689.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Patient Care Team; Botulinum Toxins [*therapeutic use]; Muscle Spasticity [drug therapy, etiology, *rehabilitation]; Neuromuscular Agents [*therapeutic use]; Randomized Controlled Trials as Topic; Stroke [*complications, drug therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009689.pub2&amp;doi=10.1002/14651858.CD009689.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="1ljSZou6";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009689\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009689\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","pt","ko","fr","ta","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009689.pub2",title:"Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post\\u2010stroke spasticity",firstPublishedDate:"Jun 5, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Stroke Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1ljSZou6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009689.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009689.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009689.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009689.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009689.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009689.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ta&quot;,&quot;title&quot;:&quot;எளியமொழிச் சுருக்கம்&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009689.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009689.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009689.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009689.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9580 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009689.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-sec-0091"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-sec-0036"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-sec-0045"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-sec-0046"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-sec-0070"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-sec-0085"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/appendices#CD009689-sec-0095"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#CD009689-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Marina Demetrios</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#CD009689-cr-0003">Fary Khan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#CD009689-cr-0004">Lynne Turner‐Stokes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#CD009689-cr-0005">Caroline Brand</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information#CD009689-cr-0006">Shane McSweeney</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information/en#CD009689-sec-0105">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 June 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009689.pub2">https://doi.org/10.1002/14651858.CD009689.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009689-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009689-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009689-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009689-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009689-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009689-abs-0003">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009689-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009689-abs-0001" lang="en"> <section id="CD009689-sec-0001"> <h3 class="title" id="CD009689-sec-0001">Background</h3> <p>Spasticity may affect stroke survivors by contributing to activity limitations, caregiver burden, pain and reduced quality of life (QoL). Spasticity management guidelines recommend multidisciplinary (MD) rehabilitation programmes following botulinum toxin (BoNT) treatment for post‐stroke spasticity. However, the evidence base for the effectiveness of MD rehabilitation is unclear. </p> </section> <section id="CD009689-sec-0002"> <h3 class="title" id="CD009689-sec-0002">Objectives</h3> <p>To assess the effectiveness of MD rehabilitation, following BoNT and other focal intramuscular treatments such as phenol, in improving activity limitations and other outcomes in adults and children with post‐stroke spasticity. To explore what settings, types and intensities of rehabilitation programmes are effective. </p> </section> <section id="CD009689-sec-0003"> <h3 class="title" id="CD009689-sec-0003">Search methods</h3> <p>We searched the Cochrane Stroke Group Trials Register (February 2012), the Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2011, Issue 12), MEDLINE (1948 to December 2011), EMBASE (1980 to January 2012), CINAHL (1982 to January 2012), AMED (1985 to January 2012), LILACS (1982 to September 2012), PEDro, REHABDATA and OpenGrey (September 2012). In an effort to identify further published, unpublished and ongoing trials we searched trials registries and reference lists, handsearched journals and contacted authors. </p> </section> <section id="CD009689-sec-0004"> <h3 class="title" id="CD009689-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that compared MD rehabilitation (delivered by two or more disciplines in conjunction with medical input) following BoNT and other focal intramuscular treatments for post‐stroke spasticity with placebo, routinely available local services, or lower levels of intervention; or studies that compared MD rehabilitation in different settings, of different types, or at different levels of intensity. We excluded RCTs that assessed the effectiveness of unidisciplinary therapy (for example physiotherapy only) or a single modality (for example stretching, casting, electrical stimulation or splinting only). The primary outcomes were validated measures of activity level (active and passive function) according to the World Health Organization's International Classification of Functioning, Disability and Health. Secondary outcomes included measures of symptoms, impairments, participation, QoL, impact on caregivers and adverse events. </p> </section> <section id="CD009689-sec-0005"> <h3 class="title" id="CD009689-sec-0005">Data collection and analysis</h3> <p>We independently selected the trials, extracted data, and assessed methodological quality using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE). Due to the limited number of included studies, with clinical, methodological and statistical heterogeneity, quantitative meta‐analysis was not possible. Therefore, GRADE provided qualitative synthesis of 'best evidence'. </p> </section> <section id="CD009689-sec-0006"> <h3 class="title" id="CD009689-sec-0006">Main results</h3> <p>We included three RCTs involving 91 participants. All three studies scored 'low quality' on the methodological quality assessment, implying high risk of bias. All studies investigated various types and intensities of outpatient rehabilitation programmes following BoNT for upper limb spasticity in adults with chronic stroke. Rehabilitation programmes included: modified constraint‐induced movement therapy (mCIMT) compared with a neurodevelopmental therapy programme; task practice therapy with cyclic functional electrical stimulation (FES) compared with task practice therapy only; and occupational, manual therapy with dynamic elbow extension splinting compared with occupational therapy only. There was 'low quality' evidence for mCIMT improving upper limb motor function and spasticity in chronic stroke survivors with residual voluntary upper limb activity, up to six months, and 'very low quality' evidence for dynamic elbow splinting and occupational therapy reducing elbow range of movement at 14 weeks. Task practice therapy with cyclic FES did not improve upper limb function more than task practice therapy alone, only at 12 weeks. No studies addressed interventions in children and those with lower limb spasticity, or after other focal intramuscular treatments for spasticity. </p> </section> <section id="CD009689-sec-0007"> <h3 class="title" id="CD009689-sec-0007">Authors' conclusions</h3> <p>At best there was 'low level' evidence for the effectiveness of outpatient MD rehabilitation in improving active function and impairments following BoNT for upper limb spasticity in adults with chronic stroke. No trials explored the effect of MD rehabilitation on 'passive function' (caring for the affected limb), caregiver burden, or the individual's priority goals for treatment. The optimal types (modalities, therapy approaches, settings) and intensities of therapy for improving activity (active and passive function) in adults and children with post‐stroke spasticity, in the short and longer term, are unclear. Further research is required to build evidence in this area. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009689-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009689-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009689-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009689-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009689-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009689-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD009689-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009689-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ta#CD009689-abs-0011">தமிழ்</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009689-abs-0006" lang="en"> <h3>Multidisciplinary rehabilitation programmes following treatment of spasticity after stroke </h3> <p>Stroke can cause muscle stiffness, spasms or tightness in the affected arm or leg, with pain and abnormal positioning of the limb. Consequently, there may be difficulties using the arm or leg in everyday activities or in caring for the affected limb. Treatments for spasticity may include botulinum toxin and other injected medications that paralyse the affected muscles. Following such injections, a multidisciplinary (MD) rehabilitation programme (usually delivered by two or more health professionals) is often employed. Interventions may include stretching, splinting, gait training, repetitive practice in using the arm for tasks, and orthotic prescription. Therapies are aimed at reducing spasticity to improve limb use or positioning, or to make it easier to care for the affected limb. The outcomes of such programmes focus on attainment of functional goals that are important to affected people in their everyday life. We included three relevant studies in the review, which investigated different types of MD rehabilitation interventions after botulinum toxin injections into the arms of 91 adults with previous stroke. There was low quality evidence for intensive forced use of the affected arm in improving spasticity, and very low quality evidence for elbow splinting with occupational therapy. We did not identify any studies of MD rehabilitation in children with post‐stroke spasticity or after other injected medications. The review findings are limited by the small number of studies that are methodologically flawed. More research is needed into what rehabilitation modalities and treatments are most effective for spasticity management following stroke. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009689-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009689-sec-0091"></div> <h3 class="title" id="CD009689-sec-0092">Implications for practice</h3> <section id="CD009689-sec-0092"> <p>There was limited evidence found in this review, which is matched by a lack of detail in recent spasticity management guidelines for recommending optimal multidisciplinary (MD) therapy programmes after BoNT. Hence clinical practices are based on a level of professional judgement and expertise with trial and error to determine which therapies are effective in an individual. Further trials are required to facilitate evidence‐based practice. </p> </section> <h3 class="title" id="CD009689-sec-0093">Implications for research</h3> <section id="CD009689-sec-0093"> <p>Robust clinical trials are required to investigate the optimal timing, types (combinations of therapy approaches and modalities) and intensities (frequency, amount and duration of therapy) of MD rehabilitation programmes that improve activity and participation after BoNT and other focal intramuscular treatments for post‐stroke spasticity. </p> <p>Future trials may consider:</p> <p> <ul id="CD009689-list-0020"> <li> <p>better methodological quality including larger sample sizes and multicentre designs with internationally agreed data sets; </p> </li> <li> <p>longer follow‐up (beyond six months) to determine the benefits of an intervention, as there may be a time lag between improvement in function and change in spasticity (<a href="./references#CD009689-bbs2-0049" title="FrancisHP , WadeDT , Turner‐StokesL , KingswellRS , DottCS , CoxonEA . Does reducing spasticity translate into functional benefit? An exploratory meta‐analysis. Journal of Neurology, Neurosurgery, and Psychiatry2004;75:1547–51. ">Francis 2004</a>), and whether the effects are maintained; </p> </li> <li> <p>development of appropriate outcome measures or consensus on a bank of measures that assess the 'activity (passive and active function) and participation' and 'environmental factors' domains of the ICF, which translate into real‐world functional abilities rather than focusing on impairments only. Other areas include addressing personal factors in the ICF that influence outcomes of rehabilitation interventions, and using appropriate patient‐centred outcomes with standardised measures to provide a more holistic picture; </p> </li> <li> <p>evaluation of the perspectives of patients and caregivers, and cost‐effectiveness of rehabilitation programmes; </p> </li> <li> <p>investigating optimal and effective mCIMT protocols;</p> </li> <li> <p>investigating the contribution of individual components of rehabilitation programmes to outcomes, individually and combined, in order to explore the 'black box' of rehabilitation. </p> </li> </ul> </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009689-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009689-sec-0036"></div> <section id="CD009689-sec-0037"> <h3 class="title" id="CD009689-sec-0037">Description of the condition</h3> <section id="CD009689-sec-0038"> <h4 class="title">Stroke and epidemiology</h4> <p>Stroke is the second leading cause of mortality and disease burden among adults aged 60 years and over (<a href="./references#CD009689-bbs2-0092" title="WHO . The World Health Report 2003: Shaping the Future. http://www.who.int/whr/2003/en/whr03_en.pdf (accessed 2 September 2011)October 2003. ">WHO 2003</a>). The global burden of stroke is expected to rise due to the ageing population. Annually, 15 million people worldwide suffer a stroke. Of these, five million die and another five million are left permanently disabled, placing a burden on families and communities (<a href="./references#CD009689-bbs2-0063" title="MackayJ , MensahG , World Health Organization (WHO). The atlas of heart disease and stroke. http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf2004:50. ">Mackay 2004</a>). </p> <p>Spasticity is a common manifestation of neurological insults such as stroke. Whilst the incidence of spasticity is not known with certainty, it has been estimated to affect 38% of stroke survivors after 12 months (<a href="./references#CD009689-bbs2-0089" title="WatkinsCL , LeathleyMJ , GregsonJM , MooreAP , SmithTL , SharmaAK . Prevalence of spasticity post stroke. Clinical Rehabilitation2002;16:515‐22. ">Watkins 2002</a>). Direct costs for stroke survivors with spasticity have been found to be approximately four times those for stroke survivors without spasticity (<a href="./references#CD009689-bbs2-0060" title="LundstromE , SmitsA , BorgJ , TerentA . Four‐fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event. Stroke2010;41(2):319–24. ">Lundstrom 2010</a>). The burden of post‐stroke spasticity is high in terms of treatment costs, quality of life (QoL) consequences, caregiver burden and the effects of comorbidities such as falls and fractures (<a href="./references#CD009689-bbs2-0048" title="EsquenaziA . The human and economic burden of poststroke spasticity and muscle overactivity. Journal of Clinical Outcomes Management2011;18(1):607‐14. ">Esquenazi 2011</a>). Thus, the condition not only considerably impacts on the person and their family members but society as a whole due to the increased demand for health care. </p> </section> <section id="CD009689-sec-0039"> <h4 class="title">Spasticity and the upper motor neurone syndrome</h4> <p>The primary feature of spasticity is hyperexcitability of muscle stretch reflexes (<a href="./references#CD009689-bbs2-0057" title="LanceJW . Spasticity: disordered motor control. In: FeldmanRG , YoungRR , KoellaWP editor(s). Symposium Synopsis. Chicago: Year Book Medical Publishers, 1980:485‐94. ">Lance 1980</a>), although this has been debated (<a href="./references#CD009689-bbs2-0069" title="PandyanAD , GregoricM , BarnesMP , WoodD , vanWijckF , BurridgeJ , et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disability and Rehabilitation2005;27(1/2):2‐6. ">Pandyan 2005</a>). Improved understanding of the complex pathophysiology and clinical interpretations of spasticity have lead to the broad definition of "a disordered sensori‐motor control, resulting from an upper motor neuron (UMN) lesion, presenting as intermittent or sustained involuntary activation of muscles" (<a href="./references#CD009689-bbs2-0069" title="PandyanAD , GregoricM , BarnesMP , WoodD , vanWijckF , BurridgeJ , et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disability and Rehabilitation2005;27(1/2):2‐6. ">Pandyan 2005</a>). This definition suggests that 'spasticity' can be used as an umbrella term to describe the positive features of the UMN syndrome. Spasticity typically develops over a few weeks following stroke due to abnormal patterns of supraspinal descending drive (<a href="./references#CD009689-bbs2-0052" title="GraciesJM . Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. Physical Medicine and Rehabilitation Clinics of North America2001;12:747‐68. ">Gracies 2001</a>). It often persists as a chronic neurological condition requiring long‐term management. </p> <p>The interaction of spasticity with other features of the UMN syndrome is complex (<a href="./references#CD009689-bbs2-0038" title="BarnesMP . Upper Motor Neurone Syndrome and Spasticity. Cambridge: Cambridge University Press, 2001. ">Barnes 2001</a>). The UMN syndrome is characterised by positive symptoms associated with muscle overactivity (such as spasticity, co‐contraction, associated reactions and clonus) and negative symptoms (such as weakness and fatigability). </p> <p>Spasticity results in stiffness and abnormal posturing of the limb due to net imbalance of forces between agonist and antagonist muscles, affecting static joint position and dynamic limb movement (<a href="./references#CD009689-bbs2-0075" title="SheeanG . Pathophysiology of spasticity. In: SheeanG editor(s). Spasticity Rehabilitation. 1st Edition. London: Churchill Communications Europe Ltd, 1998:17‐38. ">Sheean 1998</a>). It may mask the return of selective movement in a paretic limb following stroke and, in some cases, relief of spasticity may facilitate the return of active movement. However, this cannot be guaranteed as underlying weakness will often persist, limiting the functional gains to be made (<a href="./references#CD009689-bbs2-0036" title="AdaL , O'DwyerN , O'NeillE . Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: an observational study. Disability and Rehabilitation2006;28(13‐14):891‐7. ">Ada 2006</a>). </p> <p>Adaptive features of the UMN syndrome may develop due to untreated spasticity and underlying muscle weakness (<a href="./references#CD009689-bbs2-0036" title="AdaL , O'DwyerN , O'NeillE . Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: an observational study. Disability and Rehabilitation2006;28(13‐14):891‐7. ">Ada 2006</a>), including contractures and rheological changes of muscle, tendons and joints, further exacerbating limb positioning, movement and function. Elongating a spastic muscle may alter the viscoelastic and excitability properties thereby reducing muscle tone (<a href="./references#CD009689-bbs2-0052" title="GraciesJM . Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia. Physical Medicine and Rehabilitation Clinics of North America2001;12:747‐68. ">Gracies 2001</a>). However, the exact mechanisms remain uncertain. Stretching and positioning are used to maintain muscle length and prevent contractures in order to facilitate acquisition of normal postures. </p> <p>Post‐stroke spasticity may be focal (affecting a localised part of a limb) or multifocal (affecting more than one part of a limb or limbs). The overall pattern of spasticity combined with other UMN symptoms and resulting problems may be variable; hence individualised, goal‐directed treatment is essential. </p> <p>Spasticity is not always unwanted, as in some instances patients rely on spasticity to maintain function in an otherwise non‐functional limb. Yet, it should be treated when it interferes with activity or the ability to provide care to the stroke survivor, or causes pain or secondary complications. In addition to the broader effects of the UMN syndrome described above, other stroke‐related impairments such as neglect, fatigue and cognitive deficits can impact on function in conjunction with spasticity. Therefore, management is complex, requiring comprehensive multidisciplinary (MD) neurorehabilitation programmes.  </p> </section> <section id="CD009689-sec-0040"> <h4 class="title">Impact of spasticity and the World Health Organization International Classification of Functioning, Disability and Health </h4> <p>Spasticity‐associated problems can be classified according to the World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) (<a href="./references#CD009689-bbs2-0091" title="World Health Organization (WHO). International Classification of Functioning Disability and Health (ICF). WHO Geneva2001. ">WHO 2001</a>). The ICF is a framework used to describe health and disability. Understanding the impact of disease on a person at different levels facilitates the planning of individualised, goal‐directed and functionally orientated rehabilitation programmes. Goals for treatment of post‐stroke spasticity may relate to the following issues: </p> <p> <ul id="CD009689-list-0001"> <li> <p>'impairments' (problems with body structures or physiological function) such as restricted joint range of movement, pain and involuntary movements, e.g. associated reactions and spasms; </p> </li> <li> <p>'activity limitations' impacting on:</p> <ul id="CD009689-list-0002"> <li> <p> 'active' function (the execution of a functional task by the individual) such as reduced mobility, difficulty feeding or dressing limiting independence with self care, or </p> </li> <li> <p> 'passive' function (provision of care to an affected limb) such as difficulty maintaining palmar hygiene or applying a splint or orthotic, and increased caregiver burden; </p> </li> </ul> </li> <li> <p>'restrictions in participation', which are problems limiting societal participation, such as engagement in work, family roles and leisure activities, or impacting on QoL. </p> </li> </ul> </p> </section> <section id="CD009689-sec-0041"> <h4 class="title">Approaches to the management of spasticity</h4> <p>The two main approaches to the management of spasticity include pharmacological and physical interventions (<a href="./references#CD009689-bbs2-0079" title="StevensonVL . Rehabilitation in practice: spasticity management. Clinical Rehabilitation2010;24(4):293‐304. ">Stevenson 2010</a>). In clinical practice, these are often used in combination, but treatment is often piecemeal or not always provided as planned. One study reported that the majority of people with spasticity received at least one concomitant treatment following botulinum toxin (BoNT) injections, however physiotherapy and occupational therapy were not given as planned in a significant proportion of patients (<a href="./references#CD009689-bbs2-0084" title="Turner‐StokesL , AshfordS , WilliamsH . Poster 435: A UK pilot for a large international prospective cohort analysis of the use of Botulinum Toxin A (BoNT‐A) in upper limb spasticity (abstract). Physical Medicine and Rehabilitation2010;2 Suppl 9:S190–1. ">Turner‐Stokes 2010a</a>). </p> <p>Oral anti‐spasmodic agents (for example baclofen) are commonly used for generalised spasticity. However, BoNT or other focal intramuscular treatments such as phenol are increasingly used for focal or multifocal post‐stroke spasticity. BoNT is a neurotoxin, derived from the bacterium <i>Clostridium botulinum</i>, which binds pre‐synaptically to the acetylcholine receptor at the neuromuscular junction, inhibiting release of acetylcholine. It is effective in reducing spasticity by causing temporary, focal muscle weakness, lasting three to four months (<a href="./references#CD009689-bbs2-0044" title="DePaivaA , MeuniereFA , MolgoJ , AokiKR , DollyJO . Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proceedings of the National Academy of Sciences of the United States of America1999;96:3200‐5. ">De Paiva 1999</a>). Hence, it can provide a window of opportunity to maximise gains to be made during rehabilitation programmes. It can make it easier to stretch and lengthen muscles in order to prevent progression of contractures, and allow strengthening of antagonist muscles, which may improve selective movement control. BoNT has been shown to reduce muscle tone (<a href="./references#CD009689-bbs2-0040" title="BhaktaBB , CozensJA , ChamberlainMA , BamfordJM . Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2000;69:217‐21. ">Bhakta 2000</a>; <a href="./references#CD009689-bbs2-0045" title="EliaA , FilippiniG , CalandrellaD , AlbaneseA . Botulinum neurotoxins for post‐stroke spasticity in adults: a systematic review. Movement Disorders2009;24(6):801‐12. ">Elia 2009</a>) and improve passive function, such as for hand hygiene and reducing caregiver burden (<a href="./references#CD009689-bbs2-0040" title="BhaktaBB , CozensJA , ChamberlainMA , BamfordJM . Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2000;69:217‐21. ">Bhakta 2000</a>). However, the effect on active function remains unclear (<a href="./references#CD009689-bbs2-0028" title="Shaw , LC , PriceCI , vanWijckFM , ShackleyP , SteenN , BarnesMP , et al. Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain. Stroke2011;42(5):1371‐9. ">Shaw 2011</a>, <a href="./references#CD009689-bbs2-0076" title="SheeanGL . Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?. Current Opinion in Neurology2001;14:771‐6. ">Sheean 2001</a>). </p> <p>Recent guidelines and consensus statements on spasticity management advocate a holistic MD approach to rehabilitation to optimise the likelihood of treatment goals being achieved (<a href="./references#CD009689-bbs2-0047" title="EsquenaziA , NovakI , SheeanG , SingerB , WardA . International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments – introduction. European Journal of Neurology2010;17 Suppl 2:1‐8. ">Esquenazi 2010</a>; <a href="./references#CD009689-bbs2-0068" title="OlverJ , EsquenaziA , FungV , SingerB , WardA . Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. European Journal of Neurology2010;17 Suppl 2:57‐73. ">Olver 2010</a>; <a href="./references#CD009689-bbs2-0083" title="Turner‐StokesL , WardAB . Spasticity in Adults: Management using Botulinum Toxin. National Guidelines. London: Royal College of Physicians, 2009. ">Turner‐Stokes 2009</a>). This includes physicians trained in spasticity management and integrated allied health services to enable appropriate evaluation, goal setting, outcome measurement, treatment and follow‐up. However, recommendations are based on expert opinion rather than formal research evidence. </p> <p>Trials investigating non‐pharmacological interventions for post‐stroke spasticity have focused on the use of BoNT injections with or without single treatment modalities, such as casting (<a href="./references#CD009689-bbs2-0013" title="FarinaS , MiglioriniC , GandolfiM , BertolasiL , CasarottoM , ManganottiP , et al. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Functional Neurology2008;23(2):87‐91. ">Farina 2008</a>), ankle taping (<a href="./references#CD009689-bbs2-0027" title="ReiterF , DanniM , LagallaG , CeravoloG , ProvincialiL . Low‐dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Archives of Physical Medicine and Rehabilitation1998;79(5):532‐5. ">Reiter 1998</a>) or electrical stimulation (<a href="./references#CD009689-bbs2-0004" title="BaricichA , CardaS , BertoniM , MadernaL , CisariC . A single‐blinded, randomized pilot study of botulinum toxin type A combined with non‐pharmacological treatment for spastic foot. Journal of Rehabilitation Medicine2008;40(10):870‐2. ">Baricich 2008</a>; <a href="./references#CD009689-bbs2-0016" title="HesseS , ReiterF , KonradM , JahnkeMTl . Botulinum toxin type A and short‐term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double‐blind, placebo‐controlled trial. Clinical Rehabilitation1998;12(5):381‐8. ">Hesse 1998</a>). Trials of BoNT effectiveness often allow concomitant 'routine' therapy which is not controlled for and varies amongst centres (<a href="./references#CD009689-bbs2-0023" title="McCroryP , Turner‐StokesL , BaguleyI , DeGraaffS , KatrakP , SandanamJ , et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi‐centre randomized placebo controlled study of the effects on quality of life and other person‐centred outcomes. Journal of Rehabilitation Medicine2009;41:536‐44. ">McCrory 2009</a>). Additionally, therapy programmes are rarely described in any detail. The optimal timing, type, duration and intensity of therapy remains poorly defined. Similarly, the relationship between the types of rehabilitation therapies provided and patient outcomes is not known. Hence, whilst rehabilitation practices may be routine, they are often based on trial‐and‐error as they are difficult to characterise and standardise (<a href="./references#CD009689-bbs2-0043" title="DeJongG , HornS , GassawayJ , SlavinM , DijkersM . Toward a taxonomy of rehabilitation interventions: using an inductive approach to examine the 'Black Box' of rehabilitation. Archives of Physical Medicine and Rehabilitation2004;85:678‐86. ">De Jong 2004</a>).  </p> </section> </section> <section id="CD009689-sec-0042"> <h3 class="title" id="CD009689-sec-0042">Description of the intervention</h3> <p>Following BoNT or other focal intramuscular treatment, MD rehabilitation involves the provision of a co‐ordinated programme by a specialised team of health professionals, delivered by two or more disciplines (nursing, physiotherapy, occupational therapy, orthotists and others). As described in <a href="./references#CD009689-bbs2-0080" title="StiensS , O'YoungB , YoungM . Person‐centred rehabilitation: interdisciplinary intervention to enhance patient enablement. In: O'YoungB , YoungM , StiensS editor(s). Physical Medicine and Rehabilitation Secrets. 2nd Edition. USA: Hanley &amp; Belfus, 2002:4‐9. ">Stiens 2002</a>, necessary elements of a MD rehabilitation programme are: </p> <p> <ul id="CD009689-list-0003"> <li> <p>an individualised, patient‐centred plan formulated by the patient and rehabilitation team; </p> </li> <li> <p>goals derived and prioritised through a MD process, where goals are specific, measurable, achievable, realistic and timely (SMART) (<a href="./references#CD009689-bbs2-0088" title="WadeDT , Bovend’EerdtTJ . How to set SMART goals. Clinical Rehabilitation2010;24(4):382. ">Wade 2010</a>); </p> </li> <li> <p>patient participation, required to achieve the goals with improvement in the patient’s personal potential as a result; </p> </li> <li> <p>outcomes demonstrating improvement in one or more domains of the ICF. </p> </li> </ul> </p> <p>Unidisciplinary therapy (for example physiotherapy only) or single‐treatment modalities (such as casting and functional electrical stimulation) used in isolation do not comply with the definition of MD rehabilitation, therefore we excluded randomised controlled trials (RCTs) or other studies exploring such treatments.  </p> </section> <section id="CD009689-sec-0043"> <h3 class="title" id="CD009689-sec-0043">How the intervention might work</h3> <p>Post‐stroke spasticity can manifest in multiple ways, with detrimental effects on function, QoL and caregiver burden (<a href="./references#CD009689-bbs2-0040" title="BhaktaBB , CozensJA , ChamberlainMA , BamfordJM . Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2000;69:217‐21. ">Bhakta 2000</a>; <a href="./references#CD009689-bbs2-0046" title="EsquenaziA , MayerN . Botulinum toxin for the management of muscle overactivity and spasticity after stroke. Current Atherosclerosis Reports2001;3:295–8. ">Esquenazi 2001</a>). MD rehabilitation utilises a co‐ordinated, goal‐directed treatment approach to address these issues, including allied health and medical input. It encompasses multiple therapeutic interventions aimed at improving patient experience at the level of impairment, activity or participation, and educating patients and caregivers in the ongoing self‐management of spasticity. BoNT or other focal intramuscular treatments provide a window of opportunity to facilitate gains to be made during rehabilitation and, in this context, they may be considered to be an adjunct to a MD rehabilitation programme rather than vice versa (<a href="./references#CD009689-bbs2-0047" title="EsquenaziA , NovakI , SheeanG , SingerB , WardA . International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments – introduction. European Journal of Neurology2010;17 Suppl 2:1‐8. ">Esquenazi 2010</a>). </p> </section> <section id="CD009689-sec-0044"> <h3 class="title" id="CD009689-sec-0044">Why it is important to do this review</h3> <p>The effectiveness of MD rehabilitation in neurological conditions such as multiple sclerosis (<a href="./references#CD009689-bbs2-0055" title="KhanF , Turner‐StokesL , NgL , KilpatrickT , AmatyaB . Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database of Systematic Reviews2007, Issue 2. [DOI: 10.1002/14651858.CD006036.pub2] ">Khan 2007</a>), acquired brain injury (<a href="./references#CD009689-bbs2-0082" title="Turner‐StokesL , DislerP , NairA , WadeDT . Multidisciplinary rehabilitation for acquired brain injury in adults of working age. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD004170.pub2] ">Turner‐Stokes 2005</a>) and stroke (<a href="./references#CD009689-bbs2-0058" title="LanghorneP , BernhardtJ , KwakkelG . Stroke rehabilitation. Lancet2011;377(9778):1693‐702. ">Langhorne 2011</a>) has been proven. However, its effectiveness in managing post‐stroke spasticity following BoNT or other focal intramuscular treatment has not been determined. </p> <p>The general consensus is that optimal treatment of post‐stroke spasticity following BoNT requires a comprehensive MD rehabilitation programme (<a href="./references#CD009689-bbs2-0068" title="OlverJ , EsquenaziA , FungV , SingerB , WardA . Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. European Journal of Neurology2010;17 Suppl 2:57‐73. ">Olver 2010</a>; <a href="./references#CD009689-bbs2-0077" title="SheeanG , LanninN , Turner‐StokesL , RawickiB , SnowB . Botulinum toxin assessment, intervention and after‐care for upper limb hypertonicity in adults: international consensus statement. European Journal of Neurology2010;17 Suppl 2:74‐93. ">Sheean 2010</a>). However, these programmes are not always implemented and delivered in practice. </p> <p>Other Cochrane reviews are focused on the effectiveness of BoNT injections (<a href="./references#CD009689-bbs2-0062" title="LyonsBE , MooreP , BhaktaBB , BamfordJM , CardwellC , LoganID . Botulinum toxin for adult spasticity after stroke or non‐progressive brain lesion. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD002926.pub2] ">Lyons 2008</a>) or individual physical interventions (<a href="./references#CD009689-bbs2-0066" title="MonaghanK , HorganF , BlakeC , CornallC , HickeyPPM , LyonsBE , et al. Physical treatment interventions for managing spasticity after stroke. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009188] ">Monaghan 2011</a>) for spasticity management in stroke survivors. To date, no systematic review has evaluated the evidence for the effectiveness of MD rehabilitation following BoNT or other focal intramuscular treatment for post‐stroke spasticity. The optimal intensity, type, and setting of rehabilitation programmes and the effects on outcomes are unclear. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009689-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009689-sec-0045"></div> <p>To assess the effectiveness of MD rehabilitation, following BoNT and other focal intramuscular treatments such as phenol, in improving activity limitations and other outcomes in adults and children with post‐stroke spasticity. Specific questions addressed by this review were as follows. </p> <p> <ul id="CD009689-list-0004"> <li> <p>Does co‐ordinated MD rehabilitation achieve better outcomes than the absence of such services in persons with post‐stroke spasticity? </p> </li> <li> <p>What types of rehabilitation programmes are effective, and in which setting?</p> </li> <li> <p>Does a greater intensity (time, expertise, or both) of rehabilitation lead to better outcomes? </p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009689-sec-0046" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009689-sec-0046"></div> <section id="CD009689-sec-0047"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009689-sec-0048"> <h4 class="title">Types of studies</h4> <p>We included RCTs that assessed the effectiveness of MD rehabilitation programmes following BoNT or other focal intramuscular treatment for upper limb or lower limb post‐stroke spasticity, or both, with either routinely available local services or lower levels of intervention; or studies that compared MD rehabilitation programmes in different settings, of different types or at different intensities.   </p> </section> <section id="CD009689-sec-0049"> <h4 class="title">Types of participants</h4> <p>All children (less than 18 years) and adults (18 years or over) with a confirmed diagnosis of stroke who had upper or lower limb spasticity, or both. A diagnosis of stroke fulfils the clinical criteria of the World Health Organization (WHO) of 'rapidly developed clinical signs of focal (or global) disturbances of cerebral function, lasting more than 24 hours or leading to death, with no other apparent cause than of vascular origin' (<a href="./references#CD009689-bbs2-0090" title="World Health Organization. Recommendations on stroke prevention, diagnosis, and therapy. Stroke1989;20:1407‐31. ">WHO 1989</a>), with or without confirmation by a computed tomography (CT) scan or magnetic resonance imaging (MRI). A diagnosis of stroke encompassed ischaemic or haemorrhagic stroke (including subarachnoid, intraventricular or intracerebral haemorrhage). </p> <p>We did not include studies of participants with conditions other than stroke unless stroke‐specific data were provided separately or more than 75% of participants had a diagnosis of stroke. Where the proportion of the study population with stroke was &lt; 75%, we would contact study authors for data relating to stroke participants only. </p> </section> <section id="CD009689-sec-0050"> <h4 class="title">Types of interventions</h4> <p>In this review, we defined MD rehabilitation as any co‐ordinated therapy programme delivered by two or more disciplines (such as occupational therapy, physiotherapy, exercise physiology, orthotics, other allied health and nursing) in conjunction with medical input (neurologist or rehabilitation medicine physician) and aiming to achieve patient‐centred goals related to optimising activity and participation as defined by the ICF (<a href="./references#CD009689-bbs2-0091" title="World Health Organization (WHO). International Classification of Functioning Disability and Health (ICF). WHO Geneva2001. ">WHO 2001</a>). BoNT injections were administered using individualised or standardised injection protocols in both the control and intervention groups. </p> <p>Rehabilitation programmes may be delivered in:</p> <p> <ul id="CD009689-list-0005"> <li> <p>outpatient or day treatment settings, which may be located within private or public hospitals, community rehabilitation centres or specialist rehabilitation centres; </p> </li> <li> <p>home‐based settings, in the patients' own homes and local community;</p> </li> <li> <p>inpatient rehabilitation settings where care is delivered 24 hours per day, including specialised medical rehabilitation units or hospital wards. </p> </li> </ul> </p> <p>Rehabilitation programmes are individualised, thus the therapy provided can be variable and the actual content of MD care may vary from patient to patient. Therefore, we included any study that stated or implied MD care or rehabilitation provided it satisfied the definition, as stated above, and compared it with a type of control situation. </p> <p>Control situations were:</p> <p> <ul id="CD009689-list-0006"> <li> <p>no treatment;</p> </li> <li> <p>placebo or sham;</p> </li> <li> <p>other interventions, including a lower level or different types of intervention such as 'routinely available local services' (e.g. medical care or physiotherapy only), 'minimal intervention' (such as 'information only'), waiting list conditions, or interventions given in different settings and at lower intensity of intervention. </p> </li> </ul> </p> <p>We excluded RCTs that assessed the effectiveness of a unidisciplinary therapy (for example physiotherapy only) or a single intervention (for example stretching, casting, electrical stimulation or splinting only). </p> </section> <section id="CD009689-sec-0051"> <h4 class="title">Types of outcome measures</h4> <p>We expected diverse outcomes given the varied presentations of spasticity‐related problems and goals of treatment related to stroke severity. </p> <section id="CD009689-sec-0052"> <h5 class="title">Primary outcomes</h5> <p>Primary outcomes reflected the level of activity limitation according to the ICF (<a href="./references#CD009689-bbs2-0091" title="World Health Organization (WHO). International Classification of Functioning Disability and Health (ICF). WHO Geneva2001. ">WHO 2001</a>) and included: </p> <p> <ul id="CD009689-list-0007"> <li> <p>passive function (e.g. Leeds Arm Spasticity Impact Scale (<a href="./references#CD009689-bbs2-0039" title="BhaktaB , CozensJ , BamfordJ , ChamberlainMA . Use of botulinum toxin in stroke patients with severe upper limb spasticity. Journal of Neurology, Neurosurgery, and Psychiatry1996;61:30–5. ">Bhakta 1996</a>); Disability Assessment Scale (<a href="./references#CD009689-bbs2-0042" title="BrashearA , GordonM , ElovicE , KassiciehD , MarciniakC , LeeC , et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. New England Journal of Medicine2002;347(6):395–400. ">Brashear 2002</a>); Arm Activity measure (<a href="./references#CD009689-bbs2-0085" title="Turner‐StokesL , AshfordS , NairA . Poster 19: Psychometric evaluation of the Arm Activity Measure (ArmA) – a measure of active and passive function in the hemiparetic arm. Physical Medicine and Rehabilitation2010;2 Suppl 9:S13–4. ">Turner‐Stokes 2010b</a>)); </p> </li> <li> <p>active function of the upper limb (e.g. Motor Activity Log (MAL) (<a href="./references#CD009689-bbs2-0087" title="Van derLeeJH , BeckermanH , KnollDL , DeVetHC , BouterLM . Clinimetric properties of the motor activity log for the assessment of arm use in hemiparetic patients. Stroke2004;35:1410‐4. ">Van der Lee 2004</a>); or Action Research Arm Test (ARAT) (<a href="./references#CD009689-bbs2-0061" title="LyleRC . A performance test for assessment of upper limb function in physical rehabilitation treatment and research. International Journal of Rehabilitation Research1981;4:483‐92. ">Lyle 1981</a>)); </p> </li> <li> <p>active function of the lower limb with such mobility measures including tests of walking speed, balance and gait pattern (e.g. Timed Up And Go (TUAG) (<a href="./references#CD009689-bbs2-0071" title="PodsiadloD , RichardsonS . The timed up and go: a test of basic functional mobility for frail elderly persons. Journal of the American Geriatrics Society1991;39:142‐8. ">Podsiadlo 1991</a>); 10 m walk test (<a href="./references#CD009689-bbs2-0053" title="GreenJ , ForsterA . Reliability of gait speed measured by a timed walking test in patients one year after stroke. Clinical Rehabilitation2002;16:306‐14. ">Green 2002</a>)). </p> </li> </ul> </p> <p>We included the measure of achievement of intended goals for treatment, for example goal attainment scaling (<a href="./references#CD009689-bbs2-0056" title="KiresukT , ShermanR . Goal attainment scaling: a general method of evaluating comprehensive mental health programmes. Community Mental Health Journal1968;4:443‐53. ">Kiresuk 1968</a>) or other measure of goal achievement. The assimilation of individualised goals for treatment is increasingly used as an overall measure of outcome for trials of MD rehabilitation. </p> </section> <section id="CD009689-sec-0053"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes were measures of:</p> <p> <ul id="CD009689-list-0008"> <li> <p>symptoms and impairments, e.g. pain (measured by verbal scores or visual analogue scales, etc), spasm frequency, joint range of movement, involuntary movements, measures of spasticity or tone such as the Modified Ashworth Scale (MAS) (<a href="./references#CD009689-bbs2-0041" title="BohannonRW , SmithMB . Inter‐rater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy1987;67:206‐7. ">Bohannon 1987</a>) or Tardieu scale (<a href="./references#CD009689-bbs2-0065" title="MehrholzJ , WagnerK , MeissnerD , GrundmannK , ZangeC , KochR , et al. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clinical Rehabilitation2005;19(7):751–9. ">Mehrholz 2005</a>); </p> </li> </ul> <ul id="CD009689-list-0009"> <li> <p>restriction in participation and impact on caregivers, e.g. QoL measures (such as WHOQoL‐BREF (<a href="./references#CD009689-bbs2-0067" title="MurphyB , HermanH , HawthorneG , PinzoneT , EvertH . Australian WHOQoL instruments: user's manual and interpretation guide. Australian WHOQoL Field Study Centre, Melbourne, Australia2000. ">Murphy 2000</a>)), reduction of caregiver strain and burden (e.g. Caregiver Strain Index (<a href="./references#CD009689-bbs2-0073" title="RobinsonBC . Validation of a Caregiver Strain Index (CSI). Journal of Gerontology1983;38(3):344‐8. ">Robinson 1983</a>)).  </p> </li> </ul> </p> <p>We considered adverse events that may have resulted from the intervention. We defined serious adverse effects as events that were life‐threatening or required prolonged hospitalisation.  </p> <section id="CD009689-sec-0054"> <h6 class="title">Timing of outcome measures</h6> <p>We divided outcome time points into short term (up to three months) and long term (greater than three months). </p> </section> </section> </section> </section> <section id="CD009689-sec-0055"> <h3 class="title">Search methods for identification of studies</h3> <p>See the 'Specialized Register' section in the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/STROKE/frame.html" target="_blank">Cochrane Stroke Group</a> module. We searched for trials in all languages. </p> <section id="CD009689-sec-0056"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Stroke Group Trials Register was last searched by the Managing Editor on 8 February 2012. In addition, we searched the following electronic bibliographic databases: </p> <p> <ul id="CD009689-list-0010"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (<i>The Cochrane Library</i> 2011, Issue 12) (<a href="./appendices#CD009689-sec-0096">Appendix 1</a>); </p> </li> <li> <p>MEDLINE (1948 to December 2011) (<a href="./appendices#CD009689-sec-0097">Appendix 2</a>); </p> </li> <li> <p>EMBASE (1980 to January 2012) (<a href="./appendices#CD009689-sec-0098">Appendix 3</a>); </p> </li> <li> <p>CINAHL (1982 to January 2012) (<a href="./appendices#CD009689-sec-0099">Appendix 4</a>); </p> </li> <li> <p>AMED (1985 to January 2012) (<a href="./appendices#CD009689-sec-0100">Appendix 5</a>); </p> </li> <li> <p>LILACS (Latin American &amp; Caribbean Health Sciences Literature) at <a href="http://search.bvsalud.org/regional/index.php" target="_blank">http://search.bvsalud.org/regional/index.php</a> (1982 to September 2012) (<a href="./appendices#CD009689-sec-0101">Appendix 6</a>); </p> </li> <li> <p>Physiotherapy Evidence Database (PEDro) at <a href="http://www.pedro.org.au/" target="_blank">www.pedro.org.au/</a> (September 2012) (<a href="./appendices#CD009689-sec-0102">Appendix 7</a>); </p> </li> <li> <p>REHABDATA at www.naric.com/research/rehab/ (September 2012) (<a href="./appendices#CD009689-sec-0103">Appendix 8</a>). </p> </li> </ul> </p> <p>The MEDLINE search strategy was developed with the help of the Cochrane Stroke Group Trials Search Co‐ordinator and adapted for the other databases. </p> <p>We also searched the following ongoing trials registers:</p> <p> <ul id="CD009689-list-0011"> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov/</a>); </p> </li> <li> <p>EU Clinical Trials Register (<a href="http://www.clinicaltrialsregister.eu" target="_blank">www.clinicaltrialsregister.eu</a>); </p> </li> <li> <p>Stroke Trials Registry (<a href="http://www.strokecenter.org/trials/" target="_blank">www.strokecenter.org/trials/</a>); </p> </li> <li> <p>Current Controlled Trials (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>); </p> </li> <li> <p>WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>); </p> </li> <li> <p>Australian New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a>). </p> </li> </ul> </p> </section> <section id="CD009689-sec-0057"> <h4 class="title">Searching other resources</h4> <p>In an attempt to identify further published, unpublished and ongoing trials we:</p> <p> <ul id="CD009689-list-0012"> <li> <p>searched the reference lists of all retrieved articles, texts and other reviews on the topic; </p> </li> <li> <p>searched journals related to spasticity research and treatment not already searched on behalf of The Cochrane Collaboration. Handsearching of relevant journals included <i>Archives of Physical Medicine and Rehabilitation</i> (December 1995 to January 2012) using the search engine ScienceDirect, and <i>Journal of Rehabilitation Medicine</i> (January 2001 to January 2012); </p> </li> <li> <p>used the PubMed related articles feature;</p> </li> <li> <p>used the Science Citation Index Cited Reference Search for forward tracking of important articles; </p> </li> <li> <p>searched Open Grey (formerly SIGLE) (System for Information on Grey Literature in Europe) at <a href="http://www.opengrey.eu/" target="_blank">www.opengrey.eu/</a>; </p> </li> <li> <p>contacted authors, researchers and experts in the field.</p> </li> </ul> </p> </section> </section> <section id="CD009689-sec-0058"> <h3 class="title" id="CD009689-sec-0058">Data collection and analysis</h3> <section id="CD009689-sec-0059"> <h4 class="title">Selection of studies</h4> <p>Two review authors (MD, SM) independently screened all titles and abstracts of records identified from the searches of the electronic databases and excluded obviously irrelevant studies. We obtained the full texts of the remaining articles and assessed them for inclusion and appropriateness based on the previously defined inclusion criteria for eligibility. </p> <p>Once we had obtained all potentially appropriate studies, two review authors (MD, FK) independently evaluated each study for inclusion. Where they could not obtain a consensus about the possible inclusion or exclusion of any individual study, they made a final consensus decision by discussion with a third author (LTS). We did not mask studies regarding the name(s) of the author(s), institution(s) or publication source at any level of this review. </p> </section> <section id="CD009689-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>Review authors independently extracted the data (MD, LTS, CB) from each study that meet the inclusion criteria. We have individually summarised all studies that met the inclusion criteria in RevMan 5.1 (<a href="./references#CD009689-bbs2-0072" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011. ">RevMan 2011</a>) to include the following information: </p> <p> <ul id="CD009689-list-0013"> <li> <p>publication details;</p> </li> <li> <p>study design, study setting, inclusion and exclusion criteria, method of allocation, risk of bias; </p> </li> <li> <p>patient population, e.g. age, sex, type of stroke, site of spasticity;</p> </li> <li> <p>details of interventions;</p> </li> <li> <p>outcome measures;</p> </li> <li> <p>withdrawals, length and method of follow‐up, and number of participants followed up.</p> </li> </ul> </p> <p>Where insufficient data and methodological details were available, we contacted study authors to obtain further information and clarification (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). </p> </section> <section id="CD009689-sec-0061"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Three authors (MD, LTS, CB) independently assessed the methodological quality of the included studies during data extraction, using the Cochrane 'Risk of bias' tool according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 8.5 (<a href="./references#CD009689-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We assessed the following domains: random sequence generation and allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessors (detection bias), attrition bias, reporting bias, and other sources of bias. We scored each domain as 'low risk of bias', 'high risk of bias', or 'unclear risk of bias'. </p> <p>We considered studies to be of high methodological quality ('high quality studies') if the risk of bias for domain items was low. We rated studies to be of low methodological quality ('low quality studies') if there was unclear or high risk of bias for one or more domains (<a href="#CD009689-tbl-0001">Table 1</a>). The reviews authors resolved any disagreements or lack of consensus through discussion with a fourth review author (FK). </p> <div class="table" id="CD009689-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Levels of quality of individual studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Judgement of risk of bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk of bias of all domains low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High methodological quality = 'high ‐quality study'</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear or high risk of bias for one or more domains</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low methodological quality = 'low‐quality study'</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias for most domains</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low methodological quality = 'very low‐quality study'</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD009689-sec-0062"> <h4 class="title">Measures of treatment effect</h4> <p>It was not possible to pool data for quantitative analysis due to the small number of included studies, with significant heterogeneity in type and delivery of interventions, outcome measures, study designs (assessment time points and duration of follow‐up) and participant characteristics. Therefore, we presented a qualitative synthesis of the 'best evidence' based on the GRADE levels of evidence (<a href="#CD009689-tbl-0002">Table 2</a>), taking into consideration the five factors that impact on quality of evidence (<a href="#CD009689-tbl-0003">Table 3</a>) according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 12.2 (<a href="./references#CD009689-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We presented the results of individual studies in <a href="#CD009689-tbl-0004">Table 4</a>. </p> <div class="table" id="CD009689-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Levels of quality of a body of evidence in the GRADE approach</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Underlying methodology</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Quality rating</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised trials or double‐upgraded observational studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded randomised trials or upgraded observational studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Double‐downgraded randomised trials or observational studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Triple‐downgraded randomised trials or downgraded observational studies or case series/case reports </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009689-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Factors that may decrease the quality level of a body of evidence</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Limitations in the design and implementation of available studies suggesting high likelihood of bias </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. Indirectness of evidence (indirect population, intervention, control, outcomes)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3. Unexplained heterogeneity or inconsistency of results (including problems with subgroup analyses) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4. Imprecision of results (wide confidence intervals)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5. High probability of publication bias</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD009689-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Description of results of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N = 36 (N = 30 in analysis)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Summary of Results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greater improvement in active range of movement elbow extension at 14 weeks in intervention compared with control group. MAS scores for elbow flexors showed comparable changes of 9.3% and 8.6% in intervention and control groups respectively </p> <p>Statistical analysis: trends and mean changes in outcomes were assessed using Excel tables </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results in favour of the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active range of movement mean % change; 33.5 (29.6)<sup>#</sup> versus 18.7 (48.7)<sup>#</sup> in control group </p> <p><sup>#</sup>Mean (SD) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors' conclusions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study confirmed the efficacy of BoNT in tone management and occupational therapy in contracture reduction, and showed the value of dynamic splinting in maintaining gains in range of motion </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N = 32 (N = 29 in analysis)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Summary of Results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MAS improved in both groups at 4 weeks and 3 months post injection, with no between‐group differences. Median MAS score change was ‐2 in all cases, except at the elbow in the control group at 3 months where it was ‐1.5. At 6 months there was a significant reduction in MAS at elbow (P value = 0.004), wrist (P value = 0.003), and fingers (P value &lt; 0.001) in the intervention group (median MAS score change of ‐1). Benefit persisted only in the wrist flexors in the control group (P value = 0.014) </p> <p>Intervention group had statistically significant improvements compared with control group at: 6 months in MAS (elbow (P value = 0.019), wrist (P value =0.019) and fingers (P value &lt; 0.001)); and 3 and 6 months on the ARAT (P value = 0.012 and P value &lt; 0.001) and MAL (AOU (P value &lt; 0.001 and P value &lt; 0.001), QOM (P value = 0.007 and P value &lt; 0.001)). Both groups improved on the ARAT at 4 weeks, with no between‐group differences. Patient satisfaction was high in the intervention group at 3 and 6 months and declined in both groups at 6 months </p> <p>Statistical analysis: Mann‐Whitney U tests, Chi<sup>2</sup> tests or Fisher exact tests for baseline comparisons, Wilcoxon signed rank tests for within‐group change from baseline, Mann‐Whitney U test for between‐group comparisons, P value &lt; 0.05 were statistically significant </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results in favour of the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MAS at 6 months; greater reduction in MAS score for elbow (0.7, 95% CI 0.1 to 1.3; P value = 0.19), wrist (0.7, 95% CI 0.2 to 1.2; P value = 0.19), and fingers (1.2, 95% CI 0.9 to 1.5. P value &lt; 0.001), median MAS score change = ‐1 </p> <p>MAL AOU at 3 months (1.1 ± 0.5 versus 0.1 ± 0.2; P value &lt; 0.001) and 6 months (1.2 ± 0.5 versus 0.1 ± 0.2; P value &lt; 0.001) and QOM at 3 months (0.9 ± 0.6 versus 0.3 ± 0.2; P value &lt; 0.007) and 6 months (1.0 ± 0.5 versus 0.1 ± 0.1; P value &lt; 0.001) </p> <p>ARAT at 3 months (7.3 ± 5.0 versus 3.1 ± 2.6; P value = 0.012) and 6 months (7.9 ± 5.2 versus 1.2 ± 1.7; P value &lt; 0.001) </p> <p>Patient satisfaction at 3 and 6 months (93.3% and 86.7% versus 78.6% and 64.3%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors' conclusions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined BoNT and mCIMT produced significantly greater improvements in spasticity and upper extremity motor function than BoNT and conventional rehabilitation in chronic stroke patients with upper extremity spasticity, with benefits lasting up to 6 months. The combined therapy resulted in high patient satisfaction with no serious adverse events </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> N = 23 (all included in analysis)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Summary of Results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant differences between intervention and control groups for any outcome variable over time. Positive but insignificant trends toward improvement for MAL‐O, MAL‐SR and ARAT for both groups from baseline to week 6, and MAL‐SR for intervention group from 6 to 12 weeks. Control group had an insignificant trend toward deterioration in MAL‐SR from 6 to 12 weeks </p> <p>The entire cohort had significant improvements in MAL‐O (0.41 (0.24 to 0.58)), MAL‐SR (0.64 (0.32 to 0.95)) and ARAT (6.39 (3.38 to 9.4)) from baseline to week 6. Improvements in MAL‐SR (0.65 (0.33 to 0.97)) and ARAT (6.17 (2.31 to 10.03)) were sustained to week 12. Results were mean difference (95% CI) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results in favour of the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Author’s conclusions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BoNT and task practice therapy combined are effective in improving upper limb motor function and reducing spasticity in patients with chronic spastic hemiparesis. However, the cyclic FES protocol used in this study did not increase the gains achieved </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>AOU: amount of use<br/> ARAT: Action Research Arm Test<br/> BoNT: botulinum toxin<br/> FES: functional electrical stimulation<br/> MAL: Motor Activity Log<br/> MAL‐O: Motor Activity Log‐Observation<br/> MAL‐SR: Motor Activity Log‐Self Report<br/> MAS: Modified Ashworth Scale<br/> mCIMT: modified constraint‐induced movement therapy<br/> QOM: quality of movement<br/> SD: standard deviation </p> </div> </div> </section> <section id="CD009689-sec-0063"> <h4 class="title">Unit of analysis issues</h4> <p>We analysed the methodological quality of included RCTs using GRADE, as described in Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009689-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD009689-sec-0064"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors to obtain missing data. <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> did not report outcomes for the Motor Assessment Scale (MAS). On enquiry, the authors stated that "the journal requested that the MAS not be reported", but they did not provide data for this measure. </p> <p>None of the included studies had fatal flaws (withdrawals of more than 40% of patients, total or nearly total non‐adherence to the protocol, or very poor or non‐adjusted comparability in the baseline criteria). </p> </section> <section id="CD009689-sec-0065"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by examining the characteristics of the studies, the similarity between the types of participants, the interventions and the outcomes, as specified in the criteria for included studies. We reported trial strengths and limitations. </p> <p>We had planned to quantify statistical heterogeneity between studies using the I² statistic, where an I² greater than 50% indicates substantial inconsistency, as described in the <i>Cochrane Handbook for Systematic Reviews of interventions</i> (<a href="./references#CD009689-bbs2-0054" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). However, it was not possible to pool data and so no assessment of heterogeneity was required. </p> </section> <section id="CD009689-sec-0066"> <h4 class="title">Assessment of reporting biases</h4> <p>We minimised publication bias by sourcing unpublished data where possible. Where data were not reported in full for certain outcomes, we contacted study authors to request the full data set or the reason for not publishing the data (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). </p> </section> <section id="CD009689-sec-0067"> <h4 class="title">Data synthesis</h4> <p>Data synthesis was not possible.</p> </section> <section id="CD009689-sec-0068"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Due to the small number of included studies it was not possible to perform a subgroup analysis for: </p> <p> <ul id="CD009689-list-0014"> <li> <p>type of stroke and location;</p> </li> <li> <p>site of spasticity, i.e. upper or lower limb, or both;</p> </li> <li> <p>age (children, adults less than 65 years of age versus 65 years of age or older);</p> </li> <li> <p>type of rehabilitation programme (e.g. outpatient, home‐based);</p> </li> <li> <p>intensity of treatment (high intensity, low intensity); and</p> </li> <li> <p>time of treatment following stroke (acute, less than six weeks; subacute, six weeks to six months; and chronic, more than six months). </p> </li> </ul> </p> <p>Factors considered in heterogeneity included: setting, type and intensity of MD rehabilitation programmes. </p> </section> <section id="CD009689-sec-0069"> <h4 class="title">Sensitivity analysis</h4> <p>Due to the small number of included studies it was not possible to perform a sensitivity analysis to determine whether the overall results would be the same if we analysed studies above different methodological cut‐off points. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009689-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009689-sec-0070"></div> <section id="CD009689-sec-0071"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD009689-sec-0111" title="">Characteristics of included studies</a>; <a href="./references#CD009689-sec-0112" title="">Characteristics of excluded studies</a>. </p> <section id="CD009689-sec-0072"> <h4 class="title">Results of the search</h4> <p>Electronic and manual searches yielded a total of 877 titles and abstracts after removing duplicates. Of these, we selected 33 for closer scrutiny resulting in three studies being included based on the review criteria. We identified two potentially relevant ongoing trials (<a href="./references#CD009689-bbs2-0034" title="NCT00945295 . Efficacy and safety study of botulinum neurotoxin A with rehabilitation versus botulinum neurotoxin A alone in treatment of post‐stroke spasticity. ClinicalTrials.gov/show/NCT00945295 (accessed 18 January 2012). ">Graham 2009</a>; <a href="./references#CD009689-bbs2-0035" title="LanninN , CrottyM , RadcliffeJ . The effectiveness of best practise therapy after Botulinum Toxin A injections for adults diagnosed with neurological impairment and onset of spasticity. Australian New Zealand Clinical Trials Registry (ANZCTR) (http://www.anzctr.org.au) ACTRN12612000091808 (accessed 12 February 2012). ">Lannin 2011</a>). See <a href="#CD009689-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009689-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009689-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>The main reasons for exclusion were:</p> <p> <ul id="CD009689-list-0015"> <li> <p>RCTs where BoNT versus placebo was compared, with both groups receiving the same therapy programme; </p> </li> <li> <p>RCTs where the intervention being compared was not consistent with the definition of MD rehabilitation (see <a href="#CD009689-sec-0042">Description of the intervention</a>) e.g. unidisciplinary or single modality treatment only. </p> </li> </ul> </p> </section> <section id="CD009689-sec-0073"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD009689-sec-0111" title="">Characteristics of included studies</a>. </p> <p>All three included RCTs investigated MD rehabilitation programmes in the ambulatory setting, in adults with chronic stroke following BoNT for upper limb spasticity (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). They were single‐centre trials, conducted in the USA (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>) and Taiwan (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>), with small sample sizes and underpowered. </p> <section id="CD009689-sec-0074"> <h5 class="title">Participants</h5> <p>There were a total of 91 adults, with 82 included in the analyses. <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> included people with stroke as well as traumatic brain injury (TBI), with 5/13 of the control group comprising TBI participants (22% of the study population). We included the study as the intervention group consisted only of stroke patients. The five TBI patients in the control group and compared to the intervention group were matched for cognitive deficits and other neurological impairments. </p> <p>Inclusion criteria for the studies varied (see <a href="./references#CD009689-sec-0111" title="">Characteristics of included studies</a>) and included chronic stroke (greater than six months (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>) or one year (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>) following event) and moderate or severe upper limb spasticity at specified joints (MAS ≥ 2 (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>) or MAS ≥ 3 (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>)). Two studies included participants with voluntary upper limb motor activity (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>), using different criteria for inclusion. <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> based inclusion on minimal motor criteria (10 ° active extension at metacarpophalyngeal and interphalyngeal joints and 20 ° at the wrist). <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> used the Chedoke McMaster Assessment of hand impairment (<a href="./references#CD009689-bbs2-0051" title="GowlandC , StratfordP , WardM , MorelandJ , TorresinW , VanHullenaarS , et al. Measuring physical impairment and disability with the Chedoke‐McMaster Stroke Assessment. Stroke1993;24:58‐63. ">Gowland 1993</a>) and the ability to do at least one of three upper limb tasks. <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> included participants with range of movement deficits greater than 24% in elbow extension, with no criteria reflecting whether they had functional or non‐functional upper limbs. </p> </section> <section id="CD009689-sec-0075"> <h5 class="title">Rehabilitation interventions</h5> <p>All included trials compared outpatient MD rehabilitation programmes in the intervention group with an active control situation, as described in <a href="#CD009689-sec-0050">Types of interventions</a>. The types of rehabilitation programmes were diverse, based on various therapy approaches and combinations of physical modalities. <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> included 36 participants (30 completers) who had occupational, manual therapy combined with dynamic elbow splinting (Elbow Extension Dynasplint® (EED)) or occupational therapy alone. <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> included 32 participants (29 completers) comparing modified constraint induced movement therapy (mCIMT) (high intensity training of the affected upper limb whilst restraining the non‐affected upper limb) with neurodevelopmental therapy. <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> included 23 participants (18 completers) and compared task practice therapy, incorporating occupational therapy sessions and a home exercise programme, with cyclic functional electrical stimulation (FES) to facilitate grasp and release versus task practice therapy only. </p> <p>Therapy protocols, for the control and intervention groups, differed in all three studies. Variables included: programme duration; amount and frequency of therapist contact; time spent doing a home programme or other activity outside of the programme; and intensity (defined as additional total time (hours) spent doing the rehabilitation programme (therapy sessions plus home exercises or intervention) when comparing intervention to control group (<a href="./references#CD009689-bbs2-0070" title="PeuralaSH , KantanenMP , SjogrenT , PaltamaaJ , Maarit KarhulaM , HeinonenA . Effectiveness of constraint‐induced movement therapy on activity and participation after stroke: a systematic review and meta‐analysis of randomized controlled trials. Clinical Rehabilitation2011;26(3):209‐23. ">Peurala 2011</a>)). Two studies investigated high versus lower intensity programmes, with intervention groups receiving a total of more than 670 hours (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>) and 490 hours (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>) compared with controls. All participants in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> received two hours of occupational therapy weekly for 16 weeks. The intervention group additionally had education in using the EED (worn six to eight hours daily during sleep) and fortnightly visits to adjust the device. In <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> all participants had one hour of occupational therapy and one hour of physiotherapy thrice weekly for three months. The mCIMT group had a higher intensity of upper limb training during restraining of the non‐affected limb for at least five hours per day. In <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> the control group received six one‐hour sessions and the intervention group received seven one‐hour sessions of occupational therapy over 12 weeks. All participants were required to do a one‐hour daily task practice home exercise programme, during which the intervention group also wore the cyclic FES device. The frequency of therapy sessions was high (more than two sessions per week) in <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> and lower (less than or equal to two sessions per week) in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> and <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>. </p> <p>Although the studies provided generic descriptions of the therapy programmes, there was little detail or systematic analysis (conceptualising, measuring, counting) of interventions (<a href="./references#CD009689-bbs2-0043" title="DeJongG , HornS , GassawayJ , SlavinM , DijkersM . Toward a taxonomy of rehabilitation interventions: using an inductive approach to examine the 'Black Box' of rehabilitation. Archives of Physical Medicine and Rehabilitation2004;85:678‐86. ">De Jong 2004</a>), such as quantification of time spent on specific therapeutic modalities (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>). Whilst the home exercise programme (task‐specific practice) was clearly described in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>, interventions and treatments administered during the occupational therapy sessions were not mentioned. See <a href="./references#CD009689-sec-0111" title="">Characteristics of included studies</a> for descriptions of the interventions. </p> <p>Standardised protocols for upper limb BoNT injections (muscles, doses) were used in two studies (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>) and one study used individualised protocols (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). Two studies mentioned use of electromyography for needle localisation (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). </p> </section> <section id="CD009689-sec-0076"> <h5 class="title">Outcome measures</h5> <p>A measure of activity limitation, the primary outcome for this review, was used in two studies that is active upper limb function measured by the MAL and ARAT (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). Although both studies used the MAL, the versions and administration varied. The MAL, quality of upper limb use during activities of daily living, was assessed observationally rather than self‐reported in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>. Whereas the MAL was the primary outcome measure in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>, an impairment measure (MAS) was the primary outcome in <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>. <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> used impairment‐based outcome measures only that is mean per cent change in active range of movement and MAS score at the elbow. <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> was the only study to assess patient satisfaction. None of the studies considered the impact on caregivers nor used a measure of passive function or goal achievement for example GAS (which have been shown to be more sensitive measures of outcome in this context) (<a href="./references#CD009689-bbs2-0086" title="Turner‐StokesL , BaguleyI , DeGraaffS , KatrakP , DaviesL , McCroryP , et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double‐blind placebo‐controlled randomized clinical trial. Journal of Rehabilitation Medicine2010;42:81‐9. ">Turner‐Stokes 2010c</a>). Different outcome time points were used across the studies: <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> 14 weeks; <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> one, three and six months; and <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> six and 12 weeks. </p> <p>None of the included studies determined the minimal clinically important difference for the primary outcome measure. Power calculations were only provided in <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>. <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> stated that "The population of patients who completed this study (n = 30) was not adequate to power statistical analysis of variance". <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> required 16 participants in each group to power the study but only had 14 and 15 participants in the control and intervention groups respectively. The authors of <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> stated that "the group sizes in the present study were small (n = 13 and n = 10 in the no‐FES and FES groups, respectively). A larger sample size may have been more effective in detecting group differences between the FES and no‐FES treatments". </p> </section> </section> <section id="CD009689-sec-0077"> <h4 class="title">Excluded studies</h4> <p>We excluded 28 studies (see <a href="./references#CD009689-sec-0112" title="">Characteristics of excluded studies</a>) for the following reasons: </p> <p> <ul id="CD009689-list-0016"> <li> <p>the intervention was not consistent with the definition of a MD rehabilitation programme (n = 16); </p> </li> <li> <p>the comparator was BoNT versus placebo with both groups receiving the same rehabilitation programmes (n = 12). </p> </li> </ul> </p> </section> </section> <section id="CD009689-sec-0078"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD009689-sec-0111" title="">Characteristics of included studies</a> for risk of bias assessment. <a href="#CD009689-fig-0002">Figure 2</a> shows a risk of bias summary of the review authors' judgements about each risk of bias item for each included study and <a href="#CD009689-fig-0003">Figure 3</a> shows the risk of bias graph of review authors' judgements about each risk of bias item presented as percentages across all included studies. All three studies had a high risk of bias and were graded as 'low quality' based on the criteria (<a href="#CD009689-tbl-0001">Table 1</a>). </p> <div class="figure" id="CD009689-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009689-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD009689-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009689-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD009689-sec-0079"> <h4 class="title">Allocation</h4> <p>As random sequence generation and allocation concealment were often not described, we sought clarification from study authors. Randomisation methods were adequate in all studies (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). However, allocation concealment was not provided by <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> and <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> as the treating therapist and physician, respectively, had knowledge of the upcoming assignment. </p> </section> <section id="CD009689-sec-0080"> <h4 class="title">Blinding</h4> <p>In all three included studies there was a high risk of performance bias (participants and therapists were unblinded) and low risk of detection bias (outcome assessors blinded as clarified by authors). However, outcome assessors were not questioned to assess whether blinding was maintained throughout the follow‐up period. In <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> the therapy sessions were conducted at different times in an attempt to reduce the risk of performance bias. The injecting physician was blinded in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> only. </p> </section> <section id="CD009689-sec-0081"> <h4 class="title">Incomplete outcome data</h4> <p>Attrition rates were moderate to high: 16.7% (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>), 21.7% (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>), but only 9.4% in <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>. Reasons for dropouts were: decline in health status (n = 2), personal factors (n = 2), or non‐attendance at follow‐up (n = 1) (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>); or inability to attend therapy sessions due to practical reasons (n = 2) and a car accident (n = 1) (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>). Six participants were excluded in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> due to "non‐compliance with scheduled therapy sessions", which was not defined, and the time points of participant withdrawal were unclear. Only <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> performed intention‐to‐treat (ITT) analysis and compared baseline differences between completers and dropouts, with no significant differences reported. It is unknown whether dropouts or exclusions would have significantly impacted on the outcomes in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> and <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>. </p> </section> <section id="CD009689-sec-0082"> <h4 class="title">Selective reporting</h4> <p>All study outcomes were reported, except the MAS at follow‐up in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>. </p> </section> <section id="CD009689-sec-0083"> <h4 class="title">Other potential sources of bias</h4> <p>All studies were single‐centre, with small sample sizes, and were reported to be underpowered. The sample size calculation was described in <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> only, with 16 participants required in each group to achieve 90% power to detect differences between the groups of MAS ≥ 1 with standard deviation (SD) ≤ 0.9 and accounting for 5% to 10% dropouts. The authors’ conclusions must be considered in the light of the studies being underpowered and having other high risks of bias. </p> <p><a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> did not report the baseline data for time since stroke and other stroke characteristics (such as type and location). In <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> the baseline data between the groups were not entirely comparable. The control group were significantly younger (P = 0.03) and had 39% of participants with a diagnosis of TBI (versus 0% in the intervention group) as stratified randomisation by aetiology was not performed. Subgroup analysis for TBI versus stroke was not provided in the control group. The authors rationalised that the differences would not influence findings as there were similar baseline variables, cognitive function and programme adherence for TBI and stroke participants, and age was controlled for in the analysis. </p> <p><a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> reported no significant differences between the two groups for any outcome variable at any time point. Hence, the authors proceeded to present collapsed data for the entire cohort to show the benefit of task practice training for improved upper limb function. However, the confounder in this instance was the unknown influence of BoNT versus task practice therapy on outcomes, as there was no BoNT‐only group as a comparator. </p> <p>One study had a long‐term follow‐up period of six months (three months after completing the rehabilitation programme) (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>). The other studies had shorter follow‐up periods of 12 weeks (at the time of completion of the rehabilitation programme) in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> and 14 weeks (two weeks prior to completion of the therapy programme) in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>, so longer‐term impacts could not be ascertained. </p> <p>The results in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> had large standard deviations indicating that the data included a wide range of values (see below). </p> </section> </section> <section id="CD009689-sec-0084"> <h3 class="title" id="CD009689-sec-0084">Effects of interventions</h3> <p>See <a href="#CD009689-tbl-0004">Table 4</a> for the description of the results of the included studies. </p> <p>A meta‐analysis was not possible due to the clinical, methodological, and statistical heterogeneity of the included studies. </p> <p>In the three studies, the mean age ranged from 49.1 years (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>) to 58.7 years (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>) in the intervention groups and 41.2 years (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>) to 61.5 years (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>) in the control groups. The lower control group mean age in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> may have been due to inclusion of TBI participants, however this was unclear. The study populations had chronic stroke, with the mean duration following the cerebral event being 2.9 years in both groups in <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> and 4.3 and 9.7 years in the control and intervention groups respectively in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>; this was unreported in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>. Reporting of stroke characteristics varied (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). Stroke characteristics were unreported in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>. Baseline ARAT scores for the intervention groups were 32.1 ± 12.7 and 19.5 ± 13.9, and for the control groups they were 29.0 ± 14.1 and 25.8 ± 15.5 in <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> and <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> respectively. Results are the mean ± standard deviation (SD). </p> <p><a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> reported that occupational therapy in conjunction with dynamic elbow splinting (EED) resulted in a greater improvement in active range of movement elbow extension compared with the control group (occupational therapy only) at 14 weeks (33.5% (29.6%) versus 18.7% (48.7%) respectively; mean (SD)). The MAS (elbow flexors) score change was comparable in both groups. There were no measures of activity level (active or passive upper limb function), goal attainment, or patient or caregiver perspective. The authors concluded that BoNT is effective with tone management and occupational therapy in contracture reduction, and there is 'value of dynamic splinting in maintaining gains in range of motion'.  </p> <p>BoNT injection followed by mCIMT was shown to improve spasticity and upper limb motor function in chronic stroke patients with residual voluntary upper limb motor activity, more than BoNT followed by a neurodevelopmental therapy programme, with benefits maintained up to six months (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>). Both groups had significant improvements in the MAS at four weeks and three months without between‐group differences. However, the mCIMT group showed significantly greater improvements in elbow, wrist, and finger spasticity (P = 0.019, P = 0.019, and P &lt; 0.001, respectively) at six months. Compared with the control group, the mCIMT group had greater improvements on the: MAL (amount of use (AOU) and quality of movement (QOM)) at three months (1.1 ± 0.5 versus 0.1 ± 0.2; P &lt; 0.001 and 0.9 ± 0.6 versus 0.3 ± 0.2; P &lt; 0.007) and six months (1.2 ± 0.5 versus 0.1 ± 0.2; P &lt; 0.001 and 1.0 ± 0.5 versus 0.1 ± 0.1; P &lt; 0.001), and ARAT at three months (7.3 ± 5.0 versus 3.1 ± 2.6; P = 0.012) and six months (7.9 ± 5.2 versus 1.2 ± 1.7; P &lt; 0.001). Patient satisfaction was high following treatment with BoNT and mCIMT up to three months (93.3% versus 78.6% in the control group) but was not sustained beyond this (86.7% versus 64.3% in the control group at six months). </p> <p>Following BoNT, cyclic FES in addition to task practice therapy did not improve upper limb motor function and spasticity more than task practice therapy only, up to 12 weeks (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). When examining outcomes for the entire cohort, there were significant improvements in upper limb activity: MAL‐Observation 0.41 (95% CI 0.24 to 0.58), MAL‐Self Report 0.64 (95% CI 0.32 to 0.95), ARAT 6.39 (95% CI 3.38 to 9.4) from baseline to week six, MAL‐Self Report 0.65 (95% CI 0.33 to 0.97), and ARAT 6.17 (95% CI 2.31 to 10.03) to week 12. Results are mean difference (95% CI). </p> <p>No significant adverse events were reported in any of the studies.</p> <p>All three studies were of 'low' methodological quality (high risk of bias). Therefore, using GRADE methodology for best evidence synthesis (<a href="#CD009689-tbl-0002">Table 2</a>) there was: </p> <p> <ul id="CD009689-list-0017"> <li> <p>'low quality' evidence that high intensity training of the affected limb with mCIMT, compared with a lower intensity neurodevelopmental therapy programme, improved spasticity or tone (MAS) and active upper limb function (ARAT and MAL) and achieved high satisfaction in persons with residual motor function, with benefits maintained up to six months (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>); </p> </li> <li> <p>'very low quality’ evidence that a higher intensity programme of occupational therapy with additional EED assisted in maintaining active range of movement at the elbow in the short‐term, compared with occupational therapy only (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>); </p> </li> <li> <p>no evidence that task practice therapy with cyclic FES was superior to task practice therapy only in improving spasticity or tone (MAS) and upper limb motor function (MAL‐Observation, ARAT, and MAL‐Self Report) in people with residual motor function, at 12 weeks (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>). </p> </li> </ul> </p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009689-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009689-sec-0085"></div> <section id="CD009689-sec-0086"> <h3 class="title" id="CD009689-sec-0086">Summary of main results</h3> <p>This review evaluated the effectiveness of MD rehabilitation following BoNT, or other focal intramuscular treatment, in improving the activity level (primary outcome) and other outcomes (symptoms and impairments, participation restriction, caregiver burden and QoL) in adults and children with post‐stroke spasticity.  </p> <p>For chronic stroke survivors treated with BoNT for upper limb spasticity, there is: low quality evidence that mCIMT improves upper limb function in the long‐term. There is very low quality evidence that occupational therapy with additional dynamic elbow splinting (EED) improves elbow tone and contractures. There is no evidence that task practice therapy with cyclic FES provides additional short‐term benefit compared with task practice therapy alone. The quality of the existing evidence is reduced by the methodological weakness of the included studies, which were underpowered and had a high risk of bias. </p> <p>There was no available evidence for benefits of MD rehabilitation programmes compared with the absence of such services in different settings (inpatient), for lower limb spasticity, in children with stroke, or after focal intramuscular treatments for spasticity other than BoNT. Although results for intensity of therapy were presented wherever possible, it was difficult to categorise studies based on this criterion only. Subgroup analysis for type of stroke and location, and acute versus chronic stroke was not possible. There was no evidence for the benefit of MD rehabilitation interventions following BoNT for post‐stroke spasticity on passive function, community participation, goal achievement, caregiver burden and QoL. </p> </section> <section id="CD009689-sec-0087"> <h3 class="title" id="CD009689-sec-0087">Overall completeness and applicability of evidence</h3> <p>Despite some evidence for MD rehabilitation interventions for upper limb spasticity in adults with chronic stroke, many aspects of MD care for people with post‐stroke spasticity remain unproven. </p> <p>It was not possible to determine the evidence for MD interventions for lower limb spasticity in this review as available studies included single treatment modalities only, such as taping, casting, or electrical stimulation (<a href="./references#CD009689-bbs2-0004" title="BaricichA , CardaS , BertoniM , MadernaL , CisariC . A single‐blinded, randomized pilot study of botulinum toxin type A combined with non‐pharmacological treatment for spastic foot. Journal of Rehabilitation Medicine2008;40(10):870‐2. ">Baricich 2008</a>; <a href="./references#CD009689-bbs2-0016" title="HesseS , ReiterF , KonradM , JahnkeMTl . Botulinum toxin type A and short‐term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double‐blind, placebo‐controlled trial. Clinical Rehabilitation1998;12(5):381‐8. ">Hesse 1998</a>; <a href="./references#CD009689-bbs2-0017" title="JohnsonCA , BurridgeJH , StrikePW , WoodDE , SwainID . The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: a preliminary investigation. Archives of Physical Medicine and Rehabilitation2004;85(6):902‐9. ">Johnson 2004</a>). Evidence for unidisciplinary interventions is presented elsewhere (<a href="./references#CD009689-bbs2-0066" title="MonaghanK , HorganF , BlakeC , CornallC , HickeyPPM , LyonsBE , et al. Physical treatment interventions for managing spasticity after stroke. Cochrane Database of Systematic Reviews2011, Issue 7. [DOI: 10.1002/14651858.CD009188] ">Monaghan 2011</a>). There were no identified studies that included MD interventions in children or those with an acute stroke. </p> <p>The emerging evidence for the effectiveness of BoNT in stroke is in improving passive function and achieving individual goals (<a href="./references#CD009689-bbs2-0086" title="Turner‐StokesL , BaguleyI , DeGraaffS , KatrakP , DaviesL , McCroryP , et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double‐blind placebo‐controlled randomized clinical trial. Journal of Rehabilitation Medicine2010;42:81‐9. ">Turner‐Stokes 2010c</a>). However, none of the included studies addressed these particular outcomes. Two of the studies (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>) addressed active function in the minority subset of patients with residual upper limb function, for which this is a realistic goal. </p> <p>The optimal intensity, duration and frequency of therapy that should be provided are unclear. Although high intensity mCIMT was considered superior to a lower intensity neurodevelopmental therapy programme for those with voluntary upper limb activity (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>), similar benefits could be achieved with less therapist contact time if patients are motivated. Whilst other studies have shown benefits of CIMT in stroke survivors without significant spasticity, the programmes varied in terms of duration and frequency of therapy (<a href="./references#CD009689-bbs2-0070" title="PeuralaSH , KantanenMP , SjogrenT , PaltamaaJ , Maarit KarhulaM , HeinonenA . Effectiveness of constraint‐induced movement therapy on activity and participation after stroke: a systematic review and meta‐analysis of randomized controlled trials. Clinical Rehabilitation2011;26(3):209‐23. ">Peurala 2011</a>). Further studies are needed to determine optimal protocols for CIMT in stroke survivors with spasticity. </p> <p>Applying the evidence in clinical practice is challenging. Firstly, evidence for ideal patient selection criteria for spasticity management is not available. Stroke survivors with upper limb spasticity have varied clinical presentations, whereas the study populations were restricted by the strict inclusion criteria for example the degree of residual upper limb motor activity and chronicity of stroke. This may limit the relevance of the evidence to an individual patient and, conversely, the evidence cannot be generalised to the heterogeneous stroke population. Furthermore, it is challenging to replicate the study therapy protocols in real‐life due to the variability of available resources, need for specialised equipment for example the elbow extension Dynasplint® device, therapist time and expertise, consistency of therapy programmes (intensity, duration, modalities) and other confounders (therapist‐patient interaction). </p> <p>Performing high quality RCTs when investigating complex interventions such as MD spasticity management is challenging in the real world, for the reasons described below. Whilst high quality RCTs are needed, other study designs, such as the use of clinical practice improvement methodology, may assist in building on the current evidence. Data collected prospectively and retrospectively in the routine clinical setting can be used to identify the relative contributions of specific interventions and therapies (the 'black box') to rehabilitation outcomes whilst accounting for contributing patient and environmental factors (<a href="./references#CD009689-bbs2-0043" title="DeJongG , HornS , GassawayJ , SlavinM , DijkersM . Toward a taxonomy of rehabilitation interventions: using an inductive approach to examine the 'Black Box' of rehabilitation. Archives of Physical Medicine and Rehabilitation2004;85:678‐86. ">De Jong 2004</a>; <a href="./references#CD009689-bbs2-0050" title="GassawayJ , HornSD , DeJongG , SmoutRJ , ClarkC , JamesR . Applying the clinical practice improvement approach to stroke rehabilitation: methods used and baseline results. Archives of Physical Medicine and Rehabilitation2005;86 Suppl 2:S16‐33. ">Gassaway 2005</a>). This may assist clinicians in translating and generalising study findings to clinical practice. A better understanding of the processes of care in rehabilitation for spasticity management may then improve practice of care and ultimately patient outcomes. </p> <p>Despite the gaps in the literature we believe that development of integrated MD rehabilitation teams, to provide a long‐term, comprehensive continuum of care to stroke survivors affected by spasticity, is clinically important for improving outcomes. This may be facilitated by training clinicians in setting individualised SMART goals, appropriate evaluation, and assessment of meaningful outcomes for patients and their caregivers and that assess impact at the levels of the ICF, for example using GAS. Use of item banks of standardised goals for spasticity management may be helpful where there is less expertise in goal setting (<a href="./references#CD009689-bbs2-0081" title="TennantA . Goal attainment scaling: current methodological challenges. Disability and Rehabilitation2007;29(20–21):1583‐8. ">Tennant 2007</a>). </p> </section> <section id="CD009689-sec-0088"> <h3 class="title" id="CD009689-sec-0088">Quality of the evidence</h3> <p>The quality of the evidence was limited as there were only three heterogeneous, single‐centre trials of low methodological quality, prohibiting pooling of data for quantitative meta‐analysis. </p> <p>The limitations affecting the quality of the evidence in this review include:</p> <p> <ul id="CD009689-list-0018"> <li> <p>inconsistent terminology and definitions for 'spasticity', given that it is only one element of the UMN syndrome. In practice, rehabilitation interventions target various patterns of muscle overactivity, weakness, and contractures. When investigating 'spasticity' there is ambiguity in what is being treated and measured, causing difficulty in the interpretation and application of evidence (<a href="./references#CD009689-bbs2-0037" title="BakheitAM , FheodoroffK , MolteniF . Spasticity or reversible muscle hypertonia?. Journal of Rehabilitation Medicine2011;43(6):556‐7. ">Bakheit 2011</a>; <a href="./references#CD009689-bbs2-0064" title="MalhotraS , PandyanAD , DayCR , JonesPW , HermensH . Spasticity, an impairment that is poorly defined and poorly measured. Clinical Rehabilitation2009;23:651‐8. ">Malhotra 2009</a>). <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> and <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> did not define spasticity, and <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> used multiple terms such as 'hypertonicity', 'tone', and 'spasticity' with interventions aiming to reduce 'contracture'; </p> </li> <li> <p>inadequate allocation concealment (<a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a>; <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>); </p> </li> <li> <p>high risk of performance bias due to non‐blinding of treating therapists and participants (all studies). Additionally, patients may have revealed information about the intervention to outcome assessors; however this was not addressed to reduce the risk of detection bias. In rehabilitation trials blinding of participants and personnel can be particularly challenging; </p> </li> <li> <p>small sample sizes and underpowered studies. Recruitment from single‐centre trials with strict inclusion and exclusion criteria can be limiting; </p> </li> <li> <p>the influence of significant attrition rates (16.7% in <a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> and 21.7% in <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>), non‐compliance affecting retention of participants and follow‐up, excluding dropouts from analyses and outcome reporting; </p> </li> <li> <p>differences in baseline characteristics between groups (<a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a>) including age and etiology. The authors rationalised that the differences would not influence findings as there were similar baseline variables, cognitive function and programme adherence for TBI and stroke participants, and age was controlled for in the analysis; </p> </li> <li> <p>difficulty controlling for personal factors, which influence patient‐therapist interaction, compliance, and delivery of therapy thus impacting on outcomes. These include patient motivation and self‐efficacy, and activity level outside of therapy programmes, which were not assessed in any of the studies;   </p> </li> <li> <p>selection of inappropriate outcome measures that do not show change following therapy or correlate with meaningful outcomes for patients and their caregivers. Impairment measures, e.g. MAS and range of movement, or other standardised measures such as ARAT do not necessarily translate into improved function or benefits for patients and caregivers, which may be better captured through measures of passive function or individual goal attainment. </p> </li> </ul> </p> </section> <section id="CD009689-sec-0089"> <h3 class="title" id="CD009689-sec-0089">Potential biases in the review process</h3> <p>The review authors accept that there may have been a degree of:</p> <p> <ul id="CD009689-list-0019"> <li> <p>selection bias from the literature search;</p> </li> <li> <p>publication bias, if trials have not been published due to small study populations and negative results, or effects of treatments have been exaggerated in published trials. </p> </li> </ul> </p> <p>Although <a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> included participants with TBI in the control group, without subanalysis for stroke versus TBI, excluding this study would have resulted in bias in the review as 78% of the cohort had a diagnosis of stroke. </p> </section> <section id="CD009689-sec-0090"> <h3 class="title" id="CD009689-sec-0090">Agreements and disagreements with other studies or reviews</h3> <p>This review found insufficient evidence for the optimal type and intensity of MD rehabilitation programmes following BoNT for upper and lower limb spasticity, consistent with international consensus statements (<a href="./references#CD009689-bbs2-0068" title="OlverJ , EsquenaziA , FungV , SingerB , WardA . Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: international consensus statement. European Journal of Neurology2010;17 Suppl 2:57‐73. ">Olver 2010</a>; <a href="./references#CD009689-bbs2-0077" title="SheeanG , LanninN , Turner‐StokesL , RawickiB , SnowB . Botulinum toxin assessment, intervention and after‐care for upper limb hypertonicity in adults: international consensus statement. European Journal of Neurology2010;17 Suppl 2:74‐93. ">Sheean 2010</a>). Thus, recommendations advocating integrated MD rehabilitation programmes following focal spasticity management are based on expert opinion only. </p> <p>The evidence for CIMT after BoNT for post‐stroke upper limb spasticity, in improving active upper limb function (<a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>), is also supported by a cohort study (<a href="./references#CD009689-bbs2-0059" title="LevyCE , GiuffridaC , RichardsL , WuS , DavisS , NadeauSE . Botulinum Toxin A, evidence‐based exercise therapy, and constraint‐induced movement therapy for upper‐limb hemiparesis attributable to stroke a preliminary study. American Journal of Physical Medicine and Rehabilitation2007;86:696–706. ">Levy 2007</a>). This study showed benefits of two weeks of CIMT compared with a home exercise programme in patients at more than 90 days following stroke. However, unlike <a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a>, the benefits diminished by 24 weeks. Other studies have shown that CIMT improves arm motor function in stroke survivors with benefits persisting up to one year (<a href="./references#CD009689-bbs2-0093" title="WolfSL , WinsteinCJ , MillerJP , TaubE , UswatteG , MorrisD , et al. Effect of constraint‐induced movement therapy on upper extremity function 3 to 9 months after stroke. The EXCITE randomized clinical trial. JAMA2006;296(17):2095‐104. ">Wolf 2006</a>), so longer follow‐up is warranted. However, evidence for improvement in active upper limb function after BoNT is variable, being supported by a few studies (<a href="./references#CD009689-bbs2-0074" title="RousseauxM , KozlowskiO , FrogerJ . Efficacy of botulinum toxin A in upper limb function of hemiplegic patients. Journal of Neurology2002;249(1):76‐84. ">Rousseaux 2002</a>; <a href="./references#CD009689-bbs2-0078" title="SlawekJ , BoguckiA , ReclawowiczD . Botulinum toxin type A for upper limb spasticity following stroke: an open‐label study with individualised, flexible injection regimens. Neurological Sciences2005;26:32‐9. ">Slawek 2005</a>) but not by others (<a href="./references#CD009689-bbs2-0045" title="EliaA , FilippiniG , CalandrellaD , AlbaneseA . Botulinum neurotoxins for post‐stroke spasticity in adults: a systematic review. Movement Disorders2009;24(6):801‐12. ">Elia 2009</a>; <a href="./references#CD009689-bbs2-0028" title="Shaw , LC , PriceCI , vanWijckFM , ShackleyP , SteenN , BarnesMP , et al. Botulinum toxin for the upper limb after stroke (BoTULS) trial: effect on impairment, activity limitation, and pain. Stroke2011;42(5):1371‐9. ">Shaw 2011</a>; <a href="./references#CD009689-bbs2-0076" title="SheeanGL . Botulinum treatment of spasticity: why is it so difficult to show a functional benefit?. Current Opinion in Neurology2001;14:771‐6. ">Sheean 2001</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009689-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/urn:x-wiley:14651858:media:CD009689:CD009689-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_t/tCD009689-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009689-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009689-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/urn:x-wiley:14651858:media:CD009689:CD009689-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_t/tCD009689-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009689-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009689-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/urn:x-wiley:14651858:media:CD009689:CD009689-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_t/tCD009689-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009689-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/media/CDSR/CD009689/image_n/nCD009689-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD009689-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Levels of quality of individual studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b> Judgement of risk of bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Risk of bias of all domains low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High methodological quality = 'high ‐quality study'</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear or high risk of bias for one or more domains</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low methodological quality = 'low‐quality study'</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High risk of bias for most domains</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low methodological quality = 'very low‐quality study'</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Levels of quality of individual studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009689-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Levels of quality of a body of evidence in the GRADE approach</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Underlying methodology</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Quality rating</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised trials or double‐upgraded observational studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded randomised trials or upgraded observational studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Double‐downgraded randomised trials or observational studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Triple‐downgraded randomised trials or downgraded observational studies or case series/case reports </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very low</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Levels of quality of a body of evidence in the GRADE approach</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009689-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Factors that may decrease the quality level of a body of evidence</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Limitations in the design and implementation of available studies suggesting high likelihood of bias </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. Indirectness of evidence (indirect population, intervention, control, outcomes)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3. Unexplained heterogeneity or inconsistency of results (including problems with subgroup analyses) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4. Imprecision of results (wide confidence intervals)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5. High probability of publication bias</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Factors that may decrease the quality level of a body of evidence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009689-tbl-0004"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Description of results of included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD009689-bbs2-0001" title="LaiJ , FranciscoG , WillisFB . Dynamic splinting after treatment with botulinum toxin type A: a randomized controlled pilot study. Advances in Therapy2009;26(2):241‐8. ">Lai 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N = 36 (N = 30 in analysis)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Summary of Results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Greater improvement in active range of movement elbow extension at 14 weeks in intervention compared with control group. MAS scores for elbow flexors showed comparable changes of 9.3% and 8.6% in intervention and control groups respectively </p> <p>Statistical analysis: trends and mean changes in outcomes were assessed using Excel tables </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results in favour of the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Active range of movement mean % change; 33.5 (29.6)<sup>#</sup> versus 18.7 (48.7)<sup>#</sup> in control group </p> <p><sup>#</sup>Mean (SD) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors' conclusions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This study confirmed the efficacy of BoNT in tone management and occupational therapy in contracture reduction, and showed the value of dynamic splinting in maintaining gains in range of motion </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD009689-bbs2-0002" title="SunS , HsuC , SunH , HwangC , YangC , WangJ . Combined botulinum toxin type A with modified constraint induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabilitation and Neural Repair2010;24(1):34‐41. ">Sun 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N = 32 (N = 29 in analysis)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Summary of Results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MAS improved in both groups at 4 weeks and 3 months post injection, with no between‐group differences. Median MAS score change was ‐2 in all cases, except at the elbow in the control group at 3 months where it was ‐1.5. At 6 months there was a significant reduction in MAS at elbow (P value = 0.004), wrist (P value = 0.003), and fingers (P value &lt; 0.001) in the intervention group (median MAS score change of ‐1). Benefit persisted only in the wrist flexors in the control group (P value = 0.014) </p> <p>Intervention group had statistically significant improvements compared with control group at: 6 months in MAS (elbow (P value = 0.019), wrist (P value =0.019) and fingers (P value &lt; 0.001)); and 3 and 6 months on the ARAT (P value = 0.012 and P value &lt; 0.001) and MAL (AOU (P value &lt; 0.001 and P value &lt; 0.001), QOM (P value = 0.007 and P value &lt; 0.001)). Both groups improved on the ARAT at 4 weeks, with no between‐group differences. Patient satisfaction was high in the intervention group at 3 and 6 months and declined in both groups at 6 months </p> <p>Statistical analysis: Mann‐Whitney U tests, Chi<sup>2</sup> tests or Fisher exact tests for baseline comparisons, Wilcoxon signed rank tests for within‐group change from baseline, Mann‐Whitney U test for between‐group comparisons, P value &lt; 0.05 were statistically significant </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results in favour of the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MAS at 6 months; greater reduction in MAS score for elbow (0.7, 95% CI 0.1 to 1.3; P value = 0.19), wrist (0.7, 95% CI 0.2 to 1.2; P value = 0.19), and fingers (1.2, 95% CI 0.9 to 1.5. P value &lt; 0.001), median MAS score change = ‐1 </p> <p>MAL AOU at 3 months (1.1 ± 0.5 versus 0.1 ± 0.2; P value &lt; 0.001) and 6 months (1.2 ± 0.5 versus 0.1 ± 0.2; P value &lt; 0.001) and QOM at 3 months (0.9 ± 0.6 versus 0.3 ± 0.2; P value &lt; 0.007) and 6 months (1.0 ± 0.5 versus 0.1 ± 0.1; P value &lt; 0.001) </p> <p>ARAT at 3 months (7.3 ± 5.0 versus 3.1 ± 2.6; P value = 0.012) and 6 months (7.9 ± 5.2 versus 1.2 ± 1.7; P value &lt; 0.001) </p> <p>Patient satisfaction at 3 and 6 months (93.3% and 86.7% versus 78.6% and 64.3%)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Authors' conclusions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combined BoNT and mCIMT produced significantly greater improvements in spasticity and upper extremity motor function than BoNT and conventional rehabilitation in chronic stroke patients with upper extremity spasticity, with benefits lasting up to 6 months. The combined therapy resulted in high patient satisfaction with no serious adverse events </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD009689-bbs2-0003" title="WeberD , SkidmoreE , NiyonkuruC , ChangC , HuberL , MuninM . Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to Onabotulinumtoxin A and task practice therapy: a single‐blind, randomized controlled pilot study. Archives of Physical Medicine and Rehabilitation2010;91:679‐86. ">Weber 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> N = 23 (all included in analysis)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Summary of Results</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No significant differences between intervention and control groups for any outcome variable over time. Positive but insignificant trends toward improvement for MAL‐O, MAL‐SR and ARAT for both groups from baseline to week 6, and MAL‐SR for intervention group from 6 to 12 weeks. Control group had an insignificant trend toward deterioration in MAL‐SR from 6 to 12 weeks </p> <p>The entire cohort had significant improvements in MAL‐O (0.41 (0.24 to 0.58)), MAL‐SR (0.64 (0.32 to 0.95)) and ARAT (6.39 (3.38 to 9.4)) from baseline to week 6. Improvements in MAL‐SR (0.65 (0.33 to 0.97)) and ARAT (6.17 (2.31 to 10.03)) were sustained to week 12. Results were mean difference (95% CI) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Results in favour of the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Author’s conclusions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BoNT and task practice therapy combined are effective in improving upper limb motor function and reducing spasticity in patients with chronic spastic hemiparesis. However, the cyclic FES protocol used in this study did not increase the gains achieved </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>AOU: amount of use<br/> ARAT: Action Research Arm Test<br/> BoNT: botulinum toxin<br/> FES: functional electrical stimulation<br/> MAL: Motor Activity Log<br/> MAL‐O: Motor Activity Log‐Observation<br/> MAL‐SR: Motor Activity Log‐Self Report<br/> MAS: Modified Ashworth Scale<br/> mCIMT: modified constraint‐induced movement therapy<br/> QOM: quality of movement<br/> SD: standard deviation </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Description of results of included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009689.pub2/full#CD009689-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009689.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009689-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009689-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009689-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009689-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD009689-note-0003">한국어</a> </li> <li class="section-language"> <a class="" href="pt#CD009689-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ta#CD009689-note-0005">தமிழ்</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009689\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009689\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009689\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009689\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009689\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1ljSZou6&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009689.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009689.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009689.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009689.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009689.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728650155"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009689.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728650158"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009689.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec9a74a86f431',t:'MTc0MDcyODY1MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 